ABCD‐GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR‐PCI Trial

BACKGROUND: In TAILOR‐PCI, genotype‐guided selection of P2Y(12) inhibitors after percutaneous coronary intervention did not significantly reduce the risk of ischemic events at 12 months. The Age, Body Mass Index, Chronic Kidney Disease, Diabetes, and Genotyping (ABCD‐GENE) score identifies patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Capodanno, Davide, Angiolillo, Dominick J., Lennon, Ryan J., Goodman, Shaun G., Kim, Sang‐Wook, O'Cochlain, Fearghas, So, Derek Y., Sweeney, John, Rihal, Charanjit S., Farkouh, Michael, Pereira, Naveen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245815/
https://www.ncbi.nlm.nih.gov/pubmed/35132875
http://dx.doi.org/10.1161/JAHA.121.024156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245815/
https://www.ncbi.nlm.nih.gov/pubmed/35132875
http://dx.doi.org/10.1161/JAHA.121.024156

Ejemplares similares